Recurrent and persistent bleeding overall rates with or without second‐look endoscopy Rebleeding (persistent or recurrent bleeding) · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower recurrent and persistent bleeding overall rates with or without… compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Surgery rate Number requiring emergency surgery · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower surgery rate Number requiring emergency surgery compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Mortality rate Number of deaths (30‐day mortality or in‐hospital mortality) · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower mortality rate Number of deaths (30‐day mortality or in‐hospital… compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Adverse effects of endoscopy therapy Adverse effects · patients with high‐risk bleeding ulcers
Epinephrine probably leads to higher adverse effects of endoscopy therapy Adverse effects compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
All‐cause short‐term mortality: 28 days · adults with cardiogenic shock
It is very uncertain whether epinephrine changes all‐cause short‐term mortality: 28 days compared with norepinephrine (very low certainty).
1 finding from 1 review
All‐cause long‐term mortality: 60 days · adults with cardiogenic shock
It is very uncertain whether epinephrine changes all‐cause long‐term mortality: 60 days compared with norepinephrine (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 28 days · adults with cardiogenic shock
It is very uncertain whether epinephrine changes all‐cause short‐term mortality: 28 days compared with norepinephrine‐dobutamine (very low certainty).
1 finding from 1 review
All‐cause long‐term mortality · adults with cardiogenic shock
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total mortalitya · hypotensive shock
Epinephrine showed no clear difference in total mortalitya compared with norepinephrine (low certainty).
1 finding from 1 review
Duration of oxygen therapy (hours) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Need for mechanical ventilation · patients with the management of transient tachypnea of the newborn
It is very uncertain whether epinephrine changes need for mechanical ventilation (yes/no) compared with placebo, no treatment or any other drugs (very low certainty).
1 finding from 1 review
Initiation of oral feeding (days) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine probably leads to lower admissions at enrollment or < 24 hours (outpatients only) compared with placebo (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Length of stay (inpatients only) · patients with acute viral bronchiolitis
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Length of stay (inpatients only) · patients with acute viral bronchiolitis
1 finding from 1 review
Admissions (outpatients) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review